Actively Recruiting
Clinical Study of Thiopegfilgrastim for Preventing Bone Marrow Suppression in Thoracic Tumor Chemoradiotherapy
Led by Affiliated Hospital of Nantong University · Updated on 2025-12-11
30
Participants Needed
1
Research Sites
121 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a prospective observational study designed to observe and evaluate the safety and efficacy of mecapegfilgrastim in the treatment of moderate-to-severe myelosuppression associated with concurrent chemoradiotherapy. The project will provide more robust evidence-based medical support for the use of long-acting granulocyte-stimulating agents in patients undergoing concurrent chemoradiotherapy.
CONDITIONS
Official Title
Clinical Study of Thiopegfilgrastim for Preventing Bone Marrow Suppression in Thoracic Tumor Chemoradiotherapy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Aged 18 to 75 years at the time of informed consent, both sexes eligible
- Histologically or cytologically confirmed thoracic tumor (esophageal or lung cancer)
- Investigator judges patient suitable for treatment with mecapegfilgrastim or leucogen tablets
- Expected survival greater than 3 months
- Signed informed consent and willingness to comply with study visits
- Indicated for concurrent chemoradiotherapy and receiving or will receive chemotherapy with high or intermediate risk of febrile neutropenia plus additional risk factors
You will not qualify if you...
- Pregnant or lactating women
- Known allergy to mecapegfilgrastim, pegylated or non-pegylated rhG-CSF, or E. coli-derived products
- Severe comorbidities compromising patient safety or study completion
- Any other condition interfering with study conduct or result interpretation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Affiliated Hospital of Nantong University
Nantong, Jiangsu, China, 226001
Actively Recruiting
Research Team
Z
Zhiming CHEN
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here